ES2096563T3 - Dispositivo para la aplicacion de medicamentos por iontoforesis para tratamiento local o regional. - Google Patents

Dispositivo para la aplicacion de medicamentos por iontoforesis para tratamiento local o regional.

Info

Publication number
ES2096563T3
ES2096563T3 ES90100236T ES90100236T ES2096563T3 ES 2096563 T3 ES2096563 T3 ES 2096563T3 ES 90100236 T ES90100236 T ES 90100236T ES 90100236 T ES90100236 T ES 90100236T ES 2096563 T3 ES2096563 T3 ES 2096563T3
Authority
ES
Spain
Prior art keywords
application
iontoforesis
drugs
local
regional treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90100236T
Other languages
English (en)
Inventor
Justribo Jose Ramon Tomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cit Ionofor S L
Original Assignee
Cit Ionofor S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cit Ionofor S L filed Critical Cit Ionofor S L
Application granted granted Critical
Publication of ES2096563T3 publication Critical patent/ES2096563T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A61N1/306—Arrangements where at least part of the apparatus is introduced into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Electrotherapy Devices (AREA)
  • External Artificial Organs (AREA)
  • Water Treatment By Electricity Or Magnetism (AREA)

Abstract

EQUIPO PARA LA APLICACION POR INYECCION DE UN LIQUIDO ACTIVO, MEDIANTE UNO O VARIOS DISPOSITIVOS, Y LA APLICACION SIMULTANEA DE UN CAMPO ELECTRICO EN LA MISMA REGION, POR MEDIO DE UNO O MAS ELECTRODOS, CONTROLANDO EL FLUJO Y LA INTENSIDAD DEL CAMPO ASI COMO LA POLARIDAD, MEDIANTE EL USO DE DICHO EQUIPO
ES90100236T 1989-01-09 1990-01-05 Dispositivo para la aplicacion de medicamentos por iontoforesis para tratamiento local o regional. Expired - Lifetime ES2096563T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES8900058A ES2012944A6 (es) 1989-01-09 1989-01-09 Procedimiento y su dispositivo para la admionistracion de farmacos mediante ionoforesis, para tratamiento loco-regionales.

Publications (1)

Publication Number Publication Date
ES2096563T3 true ES2096563T3 (es) 1997-03-16

Family

ID=8259770

Family Applications (2)

Application Number Title Priority Date Filing Date
ES8900058A Expired - Lifetime ES2012944A6 (es) 1989-01-09 1989-01-09 Procedimiento y su dispositivo para la admionistracion de farmacos mediante ionoforesis, para tratamiento loco-regionales.
ES90100236T Expired - Lifetime ES2096563T3 (es) 1989-01-09 1990-01-05 Dispositivo para la aplicacion de medicamentos por iontoforesis para tratamiento local o regional.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES8900058A Expired - Lifetime ES2012944A6 (es) 1989-01-09 1989-01-09 Procedimiento y su dispositivo para la admionistracion de farmacos mediante ionoforesis, para tratamiento loco-regionales.

Country Status (3)

Country Link
EP (1) EP0378132B1 (es)
DE (1) DE69029208T2 (es)
ES (2) ES2012944A6 (es)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3943304A1 (de) * 1989-12-31 1991-07-11 Broermann Bernard Dr Verfahren zur lokalen anwendung von medikamenten
DE4127951C2 (de) * 1991-08-23 1994-06-09 Boehringer Ingelheim Kg Verfahren und Vorrichtung zur gegenfeldkontrollierten Iontophorese
FR2703253B1 (fr) * 1993-03-30 1995-06-23 Centre Nat Rech Scient Applicateur d'impulsions electriques pour traitement de tissus biologiques.
US5993434A (en) * 1993-04-01 1999-11-30 Genetronics, Inc. Method of treatment using electroporation mediated delivery of drugs and genes
DE4344986A1 (de) * 1993-12-30 1995-07-06 Richard Dr Knedla Ein Verfahren sowie die technische Lösung und Vorrichtung zur Durchführung einer medizinischen Elektrotherapie sowie Schnelldiagnostik bei der Behandlung von schweren Krankheiten, wie AIDS, Krebs, Tbc, Neurofibromatose etc.
WO1995021654A1 (fr) * 1994-02-10 1995-08-17 Vladimir Ivanovich Ivanov Dispositif de phono-electrophorese
AUPM982694A0 (en) * 1994-12-02 1995-01-05 University Of Queensland, The Iontophoresis method and apparatus
WO1997018855A1 (en) * 1995-11-21 1997-05-29 Eduard Naumovich Lerner Device for enhanced delivery of biologically active substances and compounds in an organism
EP0932427A1 (en) * 1997-07-22 1999-08-04 Emed Corporation Needle for iontophoretic delivery of agent
US6216034B1 (en) 1997-08-01 2001-04-10 Genetronics, Inc. Method of programming an array of needle electrodes for electroporation therapy of tissue
US6241701B1 (en) 1997-08-01 2001-06-05 Genetronics, Inc. Apparatus for electroporation mediated delivery of drugs and genes
US6055453A (en) 1997-08-01 2000-04-25 Genetronics, Inc. Apparatus for addressing needle array electrodes for electroporation therapy
WO1999036563A1 (en) * 1998-01-14 1999-07-22 Emed Corporation Electrically mediated cellular expression
CA2626830A1 (en) 1998-02-24 1999-08-26 Boston Scientific Limited High flow rate dialysis catheters and related methods
US7922709B2 (en) 1998-07-13 2011-04-12 Genetronics, Inc. Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
US6678556B1 (en) 1998-07-13 2004-01-13 Genetronics, Inc. Electrical field therapy with reduced histopathological change in muscle
EP2428250A1 (en) 1998-07-13 2012-03-14 Genetronics, Inc. Skin and muscle-targeted gene therapy by pulsed electrical field
WO2000002620A1 (en) 1998-07-13 2000-01-20 Genetronics, Inc. Method and apparatus for electrically assisted topical delivery of agents for cosmetic applications
US6300108B1 (en) 1999-07-21 2001-10-09 The Regents Of The University Of California Controlled electroporation and mass transfer across cell membranes
US6795728B2 (en) 2001-08-17 2004-09-21 Minnesota Medical Physics, Llc Apparatus and method for reducing subcutaneous fat deposits by electroporation
US6697670B2 (en) 2001-08-17 2004-02-24 Minnesota Medical Physics, Llc Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients
US6892099B2 (en) 2001-02-08 2005-05-10 Minnesota Medical Physics, Llc Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation
US8251986B2 (en) 2000-08-17 2012-08-28 Angiodynamics, Inc. Method of destroying tissue cells by eletroporation
DE10129912A1 (de) * 2001-06-21 2003-01-02 Efmt Entwicklungs Und Forschun Nadelelektrode
US6994706B2 (en) 2001-08-13 2006-02-07 Minnesota Medical Physics, Llc Apparatus and method for treatment of benign prostatic hyperplasia
USRE42016E1 (en) 2001-08-13 2010-12-28 Angiodynamics, Inc. Apparatus and method for the treatment of benign prostatic hyperplasia
US8298222B2 (en) 2003-12-24 2012-10-30 The Regents Of The University Of California Electroporation to deliver chemotherapeutics and enhance tumor regression
ES2543832T3 (es) 2003-12-24 2015-08-24 The Regents Of The University Of California Ablación de tejido con electroporación irreversible
US8114070B2 (en) 2005-06-24 2012-02-14 Angiodynamics, Inc. Methods and systems for treating BPH using electroporation
US20060293730A1 (en) 2005-06-24 2006-12-28 Boris Rubinsky Methods and systems for treating restenosis sites using electroporation
WO2008048620A2 (en) 2006-10-16 2008-04-24 The Regents Of The University Of California Gels with predetermined conductivity used in irreversible electroporation of tissue
WO2009121009A2 (en) 2008-03-27 2009-10-01 The Regents Of The University Of California Irreversible electroporation device for use in attenuating neointimal
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
WO2009134876A1 (en) 2008-04-29 2009-11-05 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation to create tissue scaffolds
US9283051B2 (en) 2008-04-29 2016-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US20090281477A1 (en) 2008-05-09 2009-11-12 Angiodynamics, Inc. Electroporation device and method
US9173704B2 (en) 2008-06-20 2015-11-03 Angiodynamics, Inc. Device and method for the ablation of fibrin sheath formation on a venous catheter
US9681909B2 (en) 2008-06-23 2017-06-20 Angiodynamics, Inc. Treatment devices and methods
WO2010085765A2 (en) 2009-01-23 2010-07-29 Moshe Meir H Therapeutic energy delivery device with rotational mechanism
WO2010093692A2 (en) 2009-02-10 2010-08-19 Hobbs Eamonn P Irreversible electroporation and tissue regeneration
US8632534B2 (en) 2009-04-03 2014-01-21 Angiodynamics, Inc. Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
WO2010118387A1 (en) 2009-04-09 2010-10-14 Virginia Tech Intellectual Properties, Inc. Integration of very short electric pulses for minimally to noninvasive electroporation
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
USD630321S1 (en) 2009-05-08 2011-01-04 Angio Dynamics, Inc. Probe handle
US8903488B2 (en) 2009-05-28 2014-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US20110118732A1 (en) 2009-11-19 2011-05-19 The Regents Of The University Of California Controlled irreversible electroporation
US9700368B2 (en) 2010-10-13 2017-07-11 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
WO2012088149A2 (en) 2010-12-20 2012-06-28 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
US9414881B2 (en) 2012-02-08 2016-08-16 Angiodynamics, Inc. System and method for increasing a target zone for electrical ablation
US9888956B2 (en) 2013-01-22 2018-02-13 Angiodynamics, Inc. Integrated pump and generator device and method of use
US10166321B2 (en) 2014-01-09 2019-01-01 Angiodynamics, Inc. High-flow port and infusion needle systems
CN112807074A (zh) 2014-05-12 2021-05-18 弗吉尼亚暨州立大学知识产权公司 电穿孔系统
US12114911B2 (en) 2014-08-28 2024-10-15 Angiodynamics, Inc. System and method for ablating a tissue site by electroporation with real-time pulse monitoring
US10694972B2 (en) 2014-12-15 2020-06-30 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
US10660691B2 (en) 2015-10-07 2020-05-26 Angiodynamics, Inc. Multiple use subassembly with integrated fluid delivery system for use with single or dual-lumen peristaltic tubing
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
US12390262B2 (en) 2018-03-13 2025-08-19 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
WO2020216290A1 (zh) * 2019-04-23 2020-10-29 上海必修福企业管理有限公司 活体内物质的运动或位置的控制方法及装置
US11950835B2 (en) 2019-06-28 2024-04-09 Virginia Tech Intellectual Properties, Inc. Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
US12214189B2 (en) 2019-07-24 2025-02-04 Virginia Tech Intellectual Properties, Inc. Fourier analysis spectroscopy for monitoring tissue impedance changes and treatment outcome during electroporation-based-therapies
US12485279B2 (en) 2020-11-25 2025-12-02 Virginia Tech Intellectual Properties, Inc. Methods for modulating temporal infrastructure of pulsed electric fields
USD1084316S1 (en) 2023-11-20 2025-07-15 Angiodynamics, Inc. Ferrule
CN120459520A (zh) * 2025-05-13 2025-08-12 海南三洲生物科技有限公司 一种基于离子极性分子的开放式汽体电极结构及使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116238A (en) * 1976-08-18 1978-09-26 Midgard Electronics Company, Inc. High voltage constant current source for iontophoresis
US4624661A (en) * 1982-11-16 1986-11-25 Surgidev Corp. Drug dispensing system
WO1986007269A1 (en) * 1985-06-10 1986-12-18 Drug Delivery Systems Inc. Programmable control and mounting system for transdermal drug applicator
ATE50915T1 (de) * 1985-06-10 1990-03-15 Drug Delivery Systems Inc Anlage und verfahren zur steuerung der elektrokinetischen lieferungsgeschwindigkeit einer arznei.
EP0313638A4 (en) * 1987-05-15 1989-06-14 Martin H Newman IONTOPHORESIS INOPHORESIS DRUG ADMINISTRATION SYSTEM.

Also Published As

Publication number Publication date
EP0378132A3 (en) 1991-03-20
ES2012944A6 (es) 1990-04-16
EP0378132B1 (en) 1996-11-27
EP0378132A2 (en) 1990-07-18
DE69029208T2 (de) 1997-06-26
DE69029208D1 (de) 1997-01-09

Similar Documents

Publication Publication Date Title
ES2012944A6 (es) Procedimiento y su dispositivo para la admionistracion de farmacos mediante ionoforesis, para tratamiento loco-regionales.
EP3915168A4 (en) ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE USING THEM
MXPA03002412A (es) Compuestos de succinimida heterociclicos fusionados y analogos de los mismos, moduladores de la funcion del receptor de la hormona nuclear.
EP3787072A4 (en) ELECTRODE PLATE AND ELECTROCHEMICAL DEVICE
ES2151926T3 (es) Electrodos mejorados para iontoforesis.
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
ES2168395T3 (es) Nueva formulacion antitrombotica, procedimiento para su preparacion y utilizacion de la misma.
ES2063102T3 (es) Imidazoles para el tratamiento de la aterosclerosis.
ES2061425T1 (es) Correccion in situ de suelos contaminados.
ES2130168T3 (es) Sistemas y metodos para erradicar los contaminantes en los fluidos.
CO5640082A2 (es) Compuestos derivados de succinimida heterociclicos fusionados que son moduladores de la funcion del receptor de la hormona nuclear y composiciones farmaceuticas que los contienen
MX380990B (es) Sistemas de suministro polimérico de acción prolongada.
ES2157220T3 (es) Aparato de ensayo analitico con control negativo y positivo incorporado.
ATE416772T1 (de) Biphenylsulfonamide als zweifach aktive rezeptor antagonisten von angiotensin und endothelin
KR960703025A (ko) 이온삼투요법용 장치(iontophoresis device)
DK0778785T3 (da) Fremgangsmåder og apparat til indgivelse af faste lægemiddelpræparater
ES2151921T3 (es) Analogo de dolastatina.
ATE297199T1 (de) Vorrichtungen und verfahren zur hitzepuls- gestützten transdermalen applikation von wirkstoffen
EP3780225A4 (en) WATER-FREE ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE WITH IT
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2194222T3 (es) Dispositivo para la administracion asistida electricamente de agentes tales como lidocaina y epinefrina.
DE60109058D1 (de) Elektrochemische vorrichtung mit ausfahrbarer elektrode
ES2082872T3 (es) Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol.
ES2068914T3 (es) Procedimiento y dispositivo para el derribo de animales de matanza.
EP3489981A4 (en) SWITCHING DEVICE, MOBILE BODY AND POWER SUPPLY SYSTEM

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 378132

Country of ref document: ES